Migraine associated with early onset postpartum depression in women with major depressive disorder.
Lifetime reproductive events
Major depressive disorder
Migraine
Postpartum depression
Women
Journal
Archives of women's mental health
ISSN: 1435-1102
Titre abrégé: Arch Womens Ment Health
Pays: Austria
ID NLM: 9815663
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
received:
26
11
2020
accepted:
03
04
2021
pubmed:
22
4
2021
medline:
30
11
2021
entrez:
21
4
2021
Statut:
ppublish
Résumé
Major depressive disorder (MDD) and migraine are both more common among women than men. Women's reproductive years are associated with increased susceptibility to recurrence of both conditions, suggesting a potential role of sex hormones in aetiology. We examined associations between comorbid migraine and clinical features of MDD in women, including relationships with lifetime reproductive events such as childbirth. Lifetime clinical characteristics and reproductive events in a well-characterised sample of 222 UK women with recurrent MDD, with (n = 98) and without (n = 124) migraine were compared. Women had all been recruited as part of a UK-based ongoing programme of research into the genetic and non-genetic determinants of mood disorders. Multivariate analysis showed a specific association between the lifetime presence of migraine and postpartum depression (PPD) within 6 weeks of delivery (OR = 2.555; 95% CI: 1.037-6.295, p = 0.041). This association did not extend to a broader definition of PPD with onset up to 6 months postpartum. All other factors included in the analysis were not significantly associated with the presence of migraine: family history of depression, younger age at depression onset, history of suicide attempt and severe premenstrual syndrome symptoms. The finding that women with MDD and comorbid migraine may be particularly sensitive to hormonal changes early in the postpartum period leads to aetiological hypotheses and suggests this group may be useful for future studies attempting to characterise PPD and MDD phenotypes. The refinement of such phenotypes has implications for individualising risk and treatment and for future biological and genetic studies.
Identifiants
pubmed: 33881600
doi: 10.1007/s00737-021-01131-6
pii: 10.1007/s00737-021-01131-6
pmc: PMC8585813
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
949-955Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Stanley Center for Psychiatric Research, Broad Institute
ID : 6045240-5500000100
Organisme : Wellcome Trust
ID : 078901
Pays : United Kingdom
Informations de copyright
© 2021. The Author(s).
Références
J Neurosci Res. 2020 Jul;98(7):1268-1282
pubmed: 30723972
Cephalalgia. 2017 Mar;37(3):251-264
pubmed: 27013238
Fertil Steril. 2008 Mar;89(3):685-92
pubmed: 17543959
Headache. 2013 Mar;53(3):498-506
pubmed: 23095134
Cephalalgia. 2000 Oct;20(8):701-7
pubmed: 11167898
Cephalalgia. 2010 Sep;30(9):1065-72
pubmed: 20713557
JAMA. 2006 Dec 6;296(21):2582-9
pubmed: 17148723
Cephalalgia. 2004;24 Suppl 1:9-160
pubmed: 14979299
J Affect Disord. 2005 Feb;84(2-3):233-42
pubmed: 15708421
Eur J Hum Genet. 2018 Aug;26(8):1202-1216
pubmed: 29995844
J Neurol Neurosurg Psychiatry. 2001 Dec;71(6):747-51
pubmed: 11723194
Neurology. 2000 Jan 25;54(2):308-13
pubmed: 10668688
Cephalalgia. 2020 Apr;40(4):347-356
pubmed: 31645113
Br J Psychiatry. 2009 Apr;194(4):350-4
pubmed: 19336787
Headache. 2013 Sep;53(8):1278-99
pubmed: 23808666
Arch Gen Psychiatry. 2006 Apr;63(4):375-82
pubmed: 16585466
Neuropeptides. 2013 Dec;47(6):363-70
pubmed: 24210135
Eur Rev Med Pharmacol Sci. 2007 Jul-Aug;11(4):245-8
pubmed: 17876959
J Womens Health (Larchmt). 2014 Sep;23(9):753-9
pubmed: 25121562
Am J Psychiatry. 2000 Jun;157(6):924-30
pubmed: 10831472
J Headache Pain. 2011 Aug;12(4):443-51
pubmed: 21442333
Psychol Med. 2014 Aug;44(11):2309-22
pubmed: 24495551
Neurology. 2016 Jul 5;87(1):49-56
pubmed: 27251885
Cephalalgia. 2007 Nov;27(11):1293-300
pubmed: 17970989
J Affect Disord. 2015 Feb 1;172:390-6
pubmed: 25451442
Neurology. 2003 Apr 22;60(8):1308-12
pubmed: 12707434
PLoS One. 2015 May 22;10(5):e0128087
pubmed: 26000962
CNS Spectr. 2015 Feb;20(1):48-59
pubmed: 25263255
Lancet Neurol. 2017 Jan;16(1):76-87
pubmed: 27836433
Arch Gen Psychiatry. 1976 Jun;33(6):766-71
pubmed: 938196
J Affect Disord. 2010 Apr;122(1-2):149-53
pubmed: 19695709
Depress Anxiety. 2000;12 Suppl 1:2-19
pubmed: 11098410
Cephalalgia. 2014 Apr;34(4):280-8
pubmed: 24101732
Mol Psychiatry. 2014 May;19(5):560-7
pubmed: 23689534
Neuropsychiatr Dis Treat. 2013;9:277-87
pubmed: 23459664
J Affect Disord. 1993 Oct-Nov;29(2-3):85-96
pubmed: 8300981
Lancet Psychiatry. 2015 Jan;2(1):59-67
pubmed: 26359613
J Fam Plann Reprod Health Care. 2007 Apr;33(2):83-93
pubmed: 17407673
Arch Gen Psychiatry. 1990 Jun;47(6):589-93
pubmed: 2190539